Purpose: The pharmacology, pharmacokinetics, clinical efficacy, adverse effects, drug interactions, and role in therapy of vildagliptin for the treatment of type 2 diabetes mellitus were reviewed.

Researchers has discovered a specific protein IL-35 that protects the immune system by lowering particular immune cells that ...

GDM is managed with medical nutritional therapy (MNT), exercise ... GDM should be differentiated from types 1 and 2 diabetes mellitus. Treatment options should be discussed.

Patients who require insulin glargine to improve metabolic control and to avoid microvascular and macrovascular complications of diabetes mellitus should, therefore, continue their treatment with ...

Diabetes Mellitus occurs when your pancreas doesn’t make enough insulin or any at all. (Image Credits: Pixabay) Diabetes Mellitus Types: Diabetes Mellitus is continues to be a major non ...

This case series documents three patients referred to the Intensive Dietary Management clinic in Toronto, Canada, for insulin-dependent type 2 diabetes ... supervised therapeutic fasting. All patients ...

Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).

The AYUSH ministry aims to combine traditional and modern medicine in order to make treatments more effective and improve ...

Monogenic diabetes mellitus (MDM ... otherwise typical escalations in therapy but with adverse side effects and ultimately inadequate glycaemic control. He was subsequently found to have a unique ...

Dr Kshetrimayum Kala SinghContd from previous issueIt is mandatory to register all the patients with necessary mobile phones, Whatsapp & e-mail for future correspondence.All the family members should ...

Drugs for diabetic kidney disease treatment have greatly expanded, allowing research and consensus on their optimal use.